Another new application of heparin in COVID-19: more than anticoagulation and antiviral
10.1136/jim-2021-001951
June 10, 2021
COVID-19
Fauci effect? When the heart is in the right place, but reality is not
10.1136/jim-2021-001949
June 1, 2021
Correlation of rate of serum albumin decline with other acute phase reactants and effect of current treatment options on serum albumin level in COVID-19
10.1136/jim-2021-001881
May 28, 2021
Dynamic albumin values as clinical surrogate for COVID-19 therapeutics
10.1136/jim-2021-001895
May 28, 2021
Dissemination of research during the first year of the coronavirus disease 2019 pandemic
10.1136/jim-2021-001923
May 28, 2021
Sensational media reporting is common when describing COVID-19 therapies, detection methods, and vaccines
10.1136/jim-2020-001760
May 21, 2021
COVID-19 reinfection: a rapid systematic review of case reports and case series
10.1136/jim-2021-001853
May 18, 2021
Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID-19
10.1136/jim-2020-001768
April 29, 2021
Hemogram as marker of in-hospital mortality in COVID-19
10.1136/jim-2021-001810
April 13, 2021
Higher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia
10.1136/jim-2020-001628
March 23, 2021